Skip to main content

Military Health System

Utility Navigation Links

TRICARE Policy Manual 6010.63-M, April 2021
Medicine
Chapter 7
Section 2.3
Family Planning
Issue Date:  August 26, 1985
Authority:  32 CFR 199.4(e)(3)
Revision:  C-24, October 31, 2024
1.0  POLICY
1.1  Medical contraceptives listed in Sections 2.1 and 2.2, as well as female tubal ligation sterilization (see note below), are covered as the clinical preventive services benefit.
1.2  In addition to the medical contraceptives listed in Section 2.1 and 2.2, the family planning procedures listed below may also be cost-shared:
1.2.1  Prescription contraceptives, including diaphragms received in the pharmacy setting, and prescription contraceptives used as emergency contraceptives.
Note:  Implantable prescription contraceptives are covered if the United States (US) Food and Drug Administration (FDA) approved and used for the labeled indication.
1.2.2  Surgical sterilization.
Note:  Tubal ligationFemale tubal sterilization procedures are covered with no-cost sharing when performed by an in network provider for TRICARE Prime and TRICARE Select beneficiaries, effective January 1, 2023. However, cost-sharing may apply when performed by an out-of-network provider or when provided to non-TRICARE Prime or TRICARE Select beneficiaries (i.e., TRICARE for Life (TFL) beneficiaries). See Section 2.2.
1.3  For preconception and prenatal carrier screening tests, see Chapter 6, Section 3.2.
2.0  EXCLUSIONS
2.1  Prophylactics (condoms).
2.2  Spermicidal foams, jellies, and sprays not requiring a prescription.
2.3  Services and supplies related to noncoital reproductive technologies, including but not limited to artificial insemination (including cost related to donors and semen banks), In Vitro Fertilization (IVF) and Gamete Intrafallopian Transfer (GIFT).
2.4  Male reversal of a surgical sterilization and reversal of a female reversal of a surgical tubal sterilization procedure, except medically necessary reversal of surgical sterilization for the treatment of a disease or injury (see Chapter 4, Sections 15.1 and 17.1).
2.5  For routine screening Papanicolaou (PAP) smear tests, routine gynecologic examinations, and related laboratory testing, see the Preventive Services policy.
2.6  The family planning benefit does not include screening PAP smear tests, routine gynecologic examinations, including related laboratory testing. However, family planning benefits may be allowed during an office visit for a screening PAP test.
- END -
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery